Alkermes
ALKS
#2327
Rank
A$11.38 B
Marketcap
A$67.77
Share price
-2.69%
Change (1 day)
53.30%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): A$0.01388

According to Alkermes's latest financial reports the company's current EPS (TTM) is A-$0.0000000000. In 2025 the company made an earnings per share (EPS) of A$2.22 a decrease over its 2024 EPS that were of A$3.36.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$0.01388-99.37%
2025A$2.22-34.08%
2024A$3.363.72%
2023A$3.24-323.96%
2022A-$1.45220%
2021A-$0.45-57.19%
2020A-$1.06-44.38%
2019A-$1.90
2017A-$1.55-24.82%
2016A-$2.07-9.87%
2015A-$2.29660%
2014A-$0.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.07-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.92-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.07-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.99-3,567,802,533,542,781,440.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$6.82-8,142,500,972,776,666,112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.74-12,826,240,470,391,560,192.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
A-$75.87 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$0.68-810,647,220,741,039,872.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel